1Turk Z, I.jubic S, Turk N, et al. Detection of Autoantibodies Against Advanced Glycation end Products and AGE-immune Complexes in Serum of Patents with Diabetes Mellitus[J]. Clin Chim Acta, 2001,303 (1/2) : 105-115.
2Schleieher E, Friess U, Oxidative Stress A G E, and Atherosclerosis[J]. Kidney Int Suppl, 2007,106(8) : S17-26.
4Zhou G, Li C, Cai L. Advanced Glycation end Products Induce Connective Tissue Growth Factor Mediated Renal Fibrosis Predominantly Through Transforming Growth Factor Beta Independent Pathway[J]. Am J Pathol, 2004, 165 (6): 2033- 2043.
5Wendt T M,Tanji N,Guo J,et al. RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephopathy[J]. Am J Pathol, 2003,162 (4) : 1123-1137.
7Greven W L,Waanders F,Nagai R,et al. Mesangial Accumulation of GA-pyridine, a Noval Glyeolaldehyde-derived AGE, in Human Renal Disease[J]. Kidney Int, 2005,68 (2) : 595-602.
8Tan A L,Forbes J M,Cooper M E. AGE,RAGE,and ROS in Diabetic Nephropathy[J ]. Semin Nephrol, 2007,27 (2) : 130- 143.
9Yamamoto Y, Yamagishi S, Yonekura H, et al. Roles of the AGE-RAGE System in Vascular in Jury in Diabetes[J]. Ann N Y Acad Sci,2000,902(5):163-170.
10Hermai A, De Servi B, Medunjanin S, et al. S100A8 and. S100A9 Activate MAP Kinase and NF Kappa B Signaling Pathways and Trigger Translocation of RAGE in Human Prostate Cancer Cells[J]. Exp Cell Res, 2006,312 : 184-197.
2Vlassara H. Pathogenic effects of advanced glycosylation: Biologic and clinical implication for diabetes and aging[J]. Lab Invest, 1994, 70: 138-147.
3Kleiner DE, Stetler-Sterenson WG, et al. Quantitative zymography: detection of picogram quantities of gelatinases[J]. Anal Biochem,1994, 218:325-329.
4Delprete D, Anglani F, Forino M, et al. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM[J]. Diabetologia, 1997, 40:1449-1454.
5Singh R, Alavi N, Singh AK, et al. Role of angiotensin II in glucose-induced inhibition of mesangial matrixde- gradation[J]. Diabetes, 1999,48(10):2066-2073.
6Derosa G, Avanzini MA, Geroldi D, et al. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes[J]. Diabetes Care,2004, 27(1):273-274.
8Zieman S,Kass D.Advanced glyeation end product cross-linking:pathophysiologic role and therapeutic target in cardiovascular disease[J].Congest Heart Fail,2004,10(3):144-149.
9Stapleton P P, Barry L K, Freeman T A, et al. Decreased peritoneal macrophage NF-jB translocation to the nucleus in protein energy malnutrition-a role for the glucocorticoid response?. Clinical Nutrition,2004,23 ( 2 ) : 177-182.
10Wei Jung- Nan, Sung Fung- chang, Li Chung- Yi, et al. Low birth weight and high birth weight infants ale both at an increased risk to have type 2 diabetes among school children in Taiwan [ J]. Diabetes Care,2003,26(2) :343-348.
